Abstract 46P
Aim/Background
The aim of the present study was to use surgical gastric cancer specimens and patient clinicopathological data to investigate the clinical significance of HMGA2 overexpression in gastric cancer. In addition, the mechanism by which HMGA2 expression acts on the gastric cancer and the association between that mechanism and EMT were analyzed in an in vitro study using a gastric cancer cell line.
Methods
The present study assessed the clinical and molecular effects of HMGA2 with the malignant tissues of 170 patients with gastric cancer and gastric cancer cells expressing HMGA2. HMGA2 expression was determined using immunohistochemistry and analyzed with respect to the clinicopathological data of patients with this tumor. In the gastric cancer cell line MKN28, in which HMGA2 was knocked down by two different short-hairpin RNAs, trans-well migration and invasion assays were conducted and western blotting was used to detect the altered expression of EMT markers.
Results
In patients with gastric cancer, HMGA2 overexpression correlated with tumor progression and was indicative of a significantly worse overall survival. Migration and invasion assays using HMGA2-knockdowned MKN28 cells showed a reduction in cell migration and invasion. The up-regulation of E-cadherin, an epithelial marker, and the down-regulation of N-cadherin, a mesenchymal marker were observed in HMGA2-knockdowned cells. In addition, expression of the transcriptional factors Snail and Zeb1 and of the EMT-pathway molecule ß-catenin were decreased.
Conclusions
HMGA2 overexpression, through its relationship to EMT, thus seems to aggravate invasion and metastasis in gastric cancer. It may therefore serve as a predictive marker in determining the clinical outcome of patients with gastric cancer and offer a promising therapeutic target.
Clinical trial identification
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
Vitamin D3 (cholecalciferol) acts as a negative regulator of breast cancer cell invasiveness in the absence of activation of classical VDR signalling
Presenter: MD Musharraf Hossain
Session: Poster presentation 1
Resources:
Abstract
VCP/p97 inhibition is a therapeutic strategy to overcome drug resistance in ovarian and pancreatic cancers
Presenter: Yuliana Astuti
Session: Poster presentation 1
Resources:
Abstract
Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis and its correlation with indoleamine 2,3-dioxygenase in breast cancer
Presenter: Kosuke Kawaguchi
Session: Poster presentation 1
Resources:
Abstract
Updated analysis: Phase II trial of irinotecan plus S-1 (IRIS) with cetuximab (IRIS/Cet) in pre-treated patients with KRAS wild type metastatic colorectal cancer (mCRC): HGCSG0902
Presenter: Ayumu Hosokawa
Session: Poster presentation 1
Resources:
Abstract
Updated analysis: observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Comparison of infusional FU/oxaliplatin (OX) + BV and oral FU/OX + BV
Presenter: Yoshito Komatsu
Session: Poster presentation 1
Resources:
Abstract
Tuberculosis exposure and the risk of cancer
Presenter: Vincent Yi-Fong Su
Session: Poster presentation 1
Resources:
Abstract
Triple negative breast cancer and androgen receptor expression: a forerunner for a novel hormonal approach
Presenter: Prameela Chelakkot G
Session: Poster presentation 1
Resources:
Abstract
Treatment of radiation induced side-effects in prostate cancer patients with hyperbaric oxygen therapy
Presenter: HAYATO Takeda
Session: Poster presentation 1
Resources:
Abstract
Tolerability and efficacy of neoadjuvant chemotherapy with three-weekly interval methotrexate, doxorubicin, vinblastine and cisplatin regimen for patients with locally advanced bladder cancer
Presenter: Satoko Arai
Session: Poster presentation 1
Resources:
Abstract
To compare the efficacy and safety of pazopanib and sunitinib in metastatic renal cell carcinoma (RCC) of Chinese population
Presenter: Michelle Fong Ting Chan
Session: Poster presentation 1
Resources:
Abstract